Clinical Trials on "Hematologic Diseases"

Total 378121 results

Duke University
National Cancer Institute (NCI); National Institutes of Health (NIH)

Recruiting

Mechanisms of Disease R/R in CAR-T for Hematologic Malignancies

Hematologic Malignancy

United States
NYU Langone Health

Active, not recruiting

A Phase II Single-arm Study of Total Body Irradiation With Linac Based VMAT and IGRT

Hematologic Malignancy

United States
Memorial Sloan Kettering Cancer Center

Completed

Haploidentical (Half-matched) Related Donor Stem Cell Transplantation Using Killer Immunoglobulin-like Receptors in Addition to Normal Selection Factors to Determine the Best Donor

Hematologic Malignancy

United States
Garcia, Jose M., MD, PhD

Active, not recruiting

Patient Fitness and Body Composition During Hematopoietic Stem Cell Transplantation

Hematologic Malignancy

United States
Duke University

Completed

Mindfulness and CBT for Sleep

Hematologic Malignancy

United States
Maisonneuve-Rosemont Hospital
Canadian Institutes of Health Research (CIHR); Hopital de l'Enfant-Jesus; St.... and other collaborators

Completed

Expanded Cord Blood in Patients in Need of an Allogeneic Stem Cell Transplant

Hematologic Malignancy

Canada
Massachusetts General Hospital

Completed

Non Invasive Optical Imaging of WBC Count

Hematologic Malignancy

United States
Alberta Health services

Unknown

Busulfan and Fludarabine as Conditioning for Allogeneic Stem Cell Transplantation: a Pharmacokinetic Study

Hematologic Malignancy

Canada
Cooperative Study Group A for Hematology

Completed

Conditioning Regimen Before Infusion of Allogeneic Hematopoietic Stem Cells

HEMATOLOGIC MALIGNANCIES

Korea, Republic of
The Affiliated People's Hospital of Ningbo University

Recruiting

Etoposide+Cytarabine+PEG-rhG-CSF as First Line Mobilization Regimen of Hematopoietic Stem Cells in Patients With Hematological Malignancies

Lymphoma | Multiple Myeloma

China
Janssen Research & Development, LLC

Recruiting

Dose Escalation Study of Teclistamab, a Humanized BCMA*CD3 Bispecific Antibody, in Participants With Relapsed or Refractory Multiple Myeloma (MajesTEC-1)

Hematological Malignancies

United States, Netherlands, Spain, France, Sweden
Sidney Kimmel Cancer Center at Thomas Jefferson...

Completed

A Study of Bone Marrow Transplantation Using Fully-Matched Relatives as Donors for Patients With Hematological Malignancies

Lymphoma | Leukemia | Multiple Myeloma | Hematological Malignancies | Hodgkin's Disease

United States
Dana-Farber Cancer Institute

Recruiting

Proof-of-Concept Trial of a Positive Psychology Intervention for Caregivers of HSCT Patients (PATH-C)

Hematologic Malignancy | Caregiver

United States
Dana-Farber Cancer Institute

Terminated

Ex Vivo TCR αβ T Cell Depletion for Graft-Versus-Host Disease Prophylaxis in Mismatched Donor Peripheral Blood Stem Cell Transplantation for Hematologic Malignancies

Hematologic Malignancy

United States
Firas El Chaer, MD

Recruiting

A Pilot Trial Using Isatuximab to Overcome Platelet Transfusion Refractoriness in Human Leukocyte Antigen Allo-Immunized Patients (SuppCare 001)

Hematologic Malignancy | Platelet Refractoriness

United States
Northside Hospital, Inc.

Recruiting

GM-CSF With Post-Transplant Cyclophosphamide

Transplant-Related Hematologic Malignancy

United States
Dialectic Therapeutics, Inc

Completed

A Study of DT2216 in Relapsed/Refractory Malignancies

Solid Tumor | Hematologic Malignancy

United States
Institut de cancérologie Strasbourg Europe

Completed

Follow-up of Actual Patient Care Site Two Months After Hospitalisation Compared With Their Expressed Choice Regarding Subsequent Care Site (RESPECT) (RESPECT)

Hematologic Malignancy | Tumor, Solid

France
University of Utah

Terminated

Phase I/II Study of Treg/Tcon Addback to Partially Matched Related Donor Stem Cells With Myeloablative Conditioning and Post-transplant Cyclophosphamide for High Risk Hematologic Malignancies

High Risk Hematologic Malignancies

United States
King Faisal Specialist Hospital & Research Center

Completed

Study Comparing G-CSF Mobilized Peripheral Blood and G-CSF Stimulated Bone Marrow in Patients Undergoing Matched Sibling Transplantation

Transplantation for Hematologic Malignancies

Saudi Arabia
M.D. Anderson Cancer Center
BTG International Inc.

Terminated

Voraxaze for Delayed Methotrexate Clearance

Solid Tumor | Hematologic Malignancy

United States
Dana-Farber Cancer Institute
National Cancer Institute (NCI); Beth Israel Deaconess Medical Center; Brigham...

Completed

Donor Dendritic Cells And Donor Lymphocytes in Patients With Relapsed Hematologic Malignancies After Allogeneic Transplant

Hematologic Malignancy

United States
Medical College of Wisconsin
National Cancer Institute (NCI); National Heart, Lung, and Blood Institute...

Completed

PROACTIVE: Preventing Acute/Chronic GVHD With TocIlizumab Combined With GVHD Prophylaxis Post allogEneic Transplant

Hematologic Malignancy

United States
Brno University Hospital

Recruiting

Telerehabilitation in Hemato-oncological Survivors (Tele@home)

Lymphoma | Hematologic Malignancy

Czechia
Bristol-Myers Squibb
Exelixis

Terminated

A Study of BMS-863233 in Patients With Hematologic Cancer

Refractory Hematologic Cancer

United States
Assistance Publique - Hôpitaux de Paris
Institut National de la Santé Et de la Recherche Médicale, France; Institut... and other collaborators

Completed

Hepatosplenic CANdidiasis : PETscan and Immune Response Analysis (CANHPARI)

Neutropenia | Hematopoietic Stem Cell Transplantation | Hematological Malignancies | Invasive Fungal Disease | Chronic Disseminated Candidiasis

France
National Institutes of Health Clinical Center (CC)

Completed

Evaluation of Patients With Blood Disorders

Hematologic Disease

United States
Maastricht University Medical Center
Dirinco B.V.

Terminated

Concentrated Citrate Locking to Reduce the Incidence of CVC-related Complications in Hematological Patients

Thrombosis | Bacteremia | Hematological Malignancies

Netherlands
University of Illinois at Chicago

Recruiting

Safety and Efficacy of Venetoclax With Escalating Doses of Omacetaxine in Patients With Acute Myeloid Leukemia Safety and Efficacy of Venetoclax With Escalating Doses of Omacetaxine in Patients With Acute Myeloid Leukemia (AML) (VEN-OM)

Relapsed or Refractory Hematologic Malignancies

United States
Memorial Sloan Kettering Cancer Center

Terminated

TCR Alpha Beta T-cell and CD19 B-cell Depleted Peripheral Blood Stem Cell Transplantation Using the CliniMACS System for Patients With Non-Malignant Hematologic Disorders From Matched or Mismatched, Related or Unrelated Donors

Non-Malignant Hematologic Disorders

United States
University of California, San Diego

Terminated

An Open Label Navigational Investigation of Molecular Profile-Related Evidence Determining Individualized Cancer Therapy for Patients With Incurable Hematologic Malignancies (I-PREDICT Heme) (I-PREDICT Heme)

Hematologic Cancer

United States
Westlake Therapeutics

Recruiting

Safety, Tolerability and Preliminary Efficacy of Engineered Red Blood Cell in Patients With Advanced Malignancies (Reboot-101)

Cancer | Solid Tumor | Hematologic Malignancy

China
City of Hope Medical Center
National Institute on Aging (NIA)

Active, not recruiting

Technology to Assess Vulnerable Older Adults With Cancer and Their Caregivers

Cancer | Solid Tumor | Hematologic Malignancy

United States
Northwestern University
National Cancer Institute (NCI); Hackensack Meridian Health; Lombardi Comprehensive...

Completed

Expressive Helping for Stem Cell Transplant Patients

Stem Cell Transplantation | Hematologic Malignancy

United States
Incyte Corporation

Completed

A Dose-escalation Study in Subjects With Advanced Malignancies

Solid Tumors and Hematologic Malignancy

United States
Medical University of Vienna

Completed

Extended Analysis for Leukemia/Lymphoma Treatment (EXALT)

Relapsed Hematologic Malignancy

Austria
Novartis Pharmaceuticals

Completed

A Study of Oral LBH589 in Adult Patients With Advanced Hematological Malignancies

Lymphoma | Leukemia | Multiple Myeloma

United States, Germany, Australia
Memorial Sloan Kettering Cancer Center

Recruiting

Genomic Profiling in Cancer Patients

Solid Tumors | Hematologic Cancers

United States
CRISPR Therapeutics AG

Enrolling by invitation

A Long-term Follow-up Study of Subjects Who Received CRISPR CAR T Cellular Therapies

Hematologic Malignancy | Solid Malignancy

United States
Chinese PLA General Hospital

Completed

GSL Synthetase Inhibitor in Combination With Immune Checkpoint Inhibitor in Previously Treated Blood and Solid Tumor

Solid Tumor | Hematologic Malignancy

China
Piramal Enterprises Limited

Completed

A Study Of Selective Cyclin Dependent Kinase Inhibitor P1446A-05 In Subjects With Advanced Refractory Malignancies (Serenity)

Solid Tumor | Hematologic Malignancy

India
Assistance Publique - Hôpitaux de Paris

Recruiting

Study Evaluating the Safety and the Efficacy of Human T Lymphoid Progenitor (HTLP) Injection to Accelerate Immune Reconstitution After Umbilical Cord Blood (UCB) Transplantation in Adult Patients With Hematologic Malignancies (HTLP-ONCO) (HTLP-ONCO)

Hematologic Malignancy

France
Sinocelltech Ltd.

Recruiting

A Clinical Study of SCTC21C in Participants With CD38+ Hematologic Malignancies

Relapsed or Refractory Hematologic Malignancies

China
Mount Sinai Hospital, Canada

Active, not recruiting

Critical Care Outcomes of Hematologic Oncology Patients (COHO)

Stem Cell Transplant | Hematologic Malignancy

Canada
Surface Oncology

Completed

Study of SRF231 in Patients With Advanced Solid and Hematologic Cancers

Hematologic Cancers | Advanced Solid Cancers

United States, Canada
Atridia Pty Ltd.

Completed

A Trial to Evaluate Safety and Tolerability of INCSHR01210 in Cancer Patients

Solid Tumors and Hematologic Malignancy

Australia
Vanda Pharmaceuticals

Unknown

Tolerability Study of Trichostatin A In Subjects With Relapsed or Refractory Hematologic Malignancies

Relapsed or Refractory Hematologic Malignancies

United States
Incyte Corporation

Completed

Open-Label Study to Assess the Safety/Tolerability in Patients With Solid Tumors

Solid Tumors and Hematologic Malignancy

United States
Yonsei University

Unknown

Prospective and Retrospective Cohort Study to Find New Prognostic Factors and Therapeutic Targets in Patients With Newly Diagnosed or Relapsed Malignant Hematologic Disorder Excluding Acute Leukemia

Malignant Hematologic Disorder

Korea, Republic of
Massachusetts General Hospital
The Leukemia and Lymphoma Society

Recruiting

Mobile CARE-App to Promote Coping for Caregivers of Patients Receiving Stem Cell Transplant

Hematologic Malignancy | Bone Marrow Transplant Complications

United States

Clinical Trials on "Hematologic Diseases"

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mongolia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations